Functional Magnetic Resonance Imaging (MRI) of Hypnosis and Mindfulness Meditation
Resting State Functional MRI Investigation of Hypnotic Trance and Mindfulness Meditation
2 other identifiers
observational
102
1 country
1
Brief Summary
Hypnotic trance and mindfulness meditation have both been shown to have benefits for physical health. The current study seeks to determine if there are distinct patterns of brain activity that correlate with hypnotic trance, mindfulness meditation or both, and to relate these patterns to measurable markers of physical well-being. Precise neuroimaging of heightened attentional states will guide future researchers and practitioners toward more effective techniques of mind/body control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 1, 2010
CompletedFirst Posted
Study publicly available on registry
June 3, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedDecember 3, 2013
December 1, 2013
2 years
June 1, 2010
December 2, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRI scan: brain activity
1 hour
Interventions
Eligibility Criteria
Healthy subjects who score in diverse ranges on hypnotic induction profiles or who are experienced Mindfulness Meditators.
You may qualify if:
- Participants must not have contraindications to the MRI exam, such as metal in the body.
You may not qualify if:
- Contraindications to the MRI exam, such as metal in the body.
- Use of psychotropic medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
Biospecimen
blood
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Spiegel
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jak, Lulu Sam Willson Professor
Study Record Dates
First Submitted
June 1, 2010
First Posted
June 3, 2010
Study Start
September 1, 2009
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
December 3, 2013
Record last verified: 2013-12